Search results
Results From The WOW.Com Content Network
Karachi Expo Center. / 24.90139°N 67.076083°E / 24.90139; 67.076083. Karachi Expo Center is the convention center where Pakistani products are showcased internationally. The center consists of 6 halls. The Trade Development Authority of Pakistan also helps support the exhibitions at the center. [1]
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in ...
Covaxin ( development name, BBV152) is a whole inactivated virus -based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research - National Institute of Virology. [ 1]
The COVID-19 pandemic in Pakistan is part of the pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).The virus was confirmed to have reached Pakistan on 26 February 2020, when two cases were recorded (a student in Karachi who had just returned from Iran and another person in the Islamabad Capital Territory). [3]
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), the virus that causes COVID-19, was isolated in late 2019. [ 1] Its genetic sequence was published on 11 January 2020, triggering an urgent international response to prepare for an outbreak and hasten the development of a preventive COVID-19 vaccine. [ 2][ 3][ 4] Since 2020, vaccine ...
COVID-19 vaccination programme Per capita fully vaccination map as of 4 April 2023 Date 16 January 2021 (2021-01-16) – present (3 years, 208 days ago) Location India Cause COVID-19 pandemic in India Target Immunisation of Indians against COVID-19 Budget ₹ 35,000 crore (US$4.2 billion) Organised by Government of India Indian Council of Medical Research State governments of India ...
The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria[6]and Covishield,[7]is a viral vector vaccine[8]produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations. [8][9][10]Finland, Denmark, and Norway suspended the use of the Oxford ...
Data has shown that COVID-19 vaccines can reduce the risk of severe disease, hospitalization and death as well as lower the risk of developing long COVID. A September 2023 analysisby the CDC ...